Minimizing ICU Neurological Dysfunction with Dexmedetomidineinduced Sleep (MINDDS): protocol for a randomised, double-blind, parallelarm, placebo-controlled trial.

MLA

Shelton, Kenneth T., et al. “Minimizing ICU Neurological Dysfunction with Dexmedetomidineinduced Sleep (MINDDS): Protocol for a Randomised, Double-Blind, Parallelarm, Placebo-Controlled Trial.” BMJ Open, vol. 8, no. 4, Apr. 2018, pp. 1–8. EBSCOhost, https://doi.org/10.1136/bmjopen-2017-020316.

APA

Shelton, K. T., Qu, J., Bilotta, F., Brown, E. N., Cudemus, G., D’Alessandro, D. A., Hao Deng, DiBiasio, A., Gitlin, J. A., Hahm, E. Y., Hobbs, L. E., Houle, T. T., Ibala, R., Loggia, M., Pavone, K. J., Shaefi, S., Tolis, G., Westover, M. B., & Akeju, O. (2018). Minimizing ICU Neurological Dysfunction with Dexmedetomidineinduced Sleep (MINDDS): protocol for a randomised, double-blind, parallelarm, placebo-controlled trial. BMJ Open, 8(4), 1–8. https://doi.org/10.1136/bmjopen-2017-020316

Chicago

Shelton, Kenneth T., Jason Qu, Federico Bilotta, Emery N. Brown, Gaston Cudemus, David A. D’Alessandro, Hao Deng, et al. 2018. “Minimizing ICU Neurological Dysfunction with Dexmedetomidineinduced Sleep (MINDDS): Protocol for a Randomised, Double-Blind, Parallelarm, Placebo-Controlled Trial.” BMJ Open 8 (4): 1–8. doi:10.1136/bmjopen-2017-020316.